Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 5 recruiting now full pipeline small index

Chronic Pelvic Pain: full-pipeline trial registry

5 of 9 indexed Chronic Pelvic Pain trials are currently recruiting.

Corpus placement: #1,916 of 28,707 conditions by registered trial count.

9 US clinical trials · 5 currently recruiting · #1,916 of 28,707 conditions by registered trial count

Chronic Pelvic Pain: 9 US clinical trials tracked, 5 recruiting.

Chronic Pelvic Pain is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of Michigan, running 2 of these trials.

Enrollment posture brief

Registry condition chronic-pelvic-pain

OPEN 5 | RECR 56% | LATE 1 | EARLY 1 | RANK #1916 | SPON 2

Nearest open-share peer: Advanced Colorectal Cancer (56% recruiting · 9 trials)

Chronic Pelvic Pain (this)56%Acute Lymphoblastic Leukemia55.6%Acute Respiratory Distress S55.6%Acute Otitis Media22.2%Acute Heart Failure11.1%
Open-enrollment share among volume-matched conditions near Chronic Pelvic Pain

Chronic Pelvic Pain lists 5 open slots (56% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Chronic Pelvic Pain on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Chronic Pelvic Pain is recruiting above its size-band peers.

    5 of 9 indexed trials (55.6%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Chronic Pelvic Pain research.

    University of Michigan accounts for 2 of 9 trials (22.2%). 8 distinct sponsors appear on at least one study for this condition label.

  3. Typical Chronic Pelvic Pain enrolment sits around 125 participants.

    Median target enrolment is 125 among the 9 trials that report a genuine target (sentinel values excluded). 4 of those (44.4%) plan for fewer than 100 participants.

  4. Chronic Pelvic Pain splits between interventional and observational designs.

    6 interventional and 3 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21Phase 41

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 4 1

Named interventions

Most-linked intervention names on Chronic Pelvic Pain records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

tDCS Procedure
1 trials
Control Group website Behavioral
1 trials
My Pelvic Plan Website Behavioral
1 trials
SoLa Pelvic Therapy Device
1 trials
Brief pain exposure therapy (BPET) Behavioral
1 trials
Saluda Evoke Smart SCS System Device
1 trials
Physical conditioning Other
1 trials
Pelvic floor yoga Other
1 trials

US sites by state

Facility locations filed on Chronic Pelvic Pain trials. A trial with sites in several states counts in each.

Michigan 2 trials
Illinois 2 trials
California 2 trials
Texas 1 trials
Ohio 1 trials
New York 1 trials
Maryland 1 trials
Massachusetts 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Chronic Pelvic Pain page

9 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Chronic Pelvic Pain condition card totals 9 registered trials; most-linked intervention tDCS; top US site state Michigan. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.